Integrated Chinese Herbal Medicine Therapy Improves the Survival of Patients With Ovarian Cancer

Background: Ovarian cancer is the seventh most commonly diagnosed malignancy worldwide and has the highest mortality rate among all gynecological cancers. Chinese herbal medicine (CHM) is widely applied in Taiwan and has been used in integrated therapies to treat patients with cancer. Methods: Patie...

Full description

Bibliographic Details
Main Authors: Cherry Yin-Yi Chang MD, PhD, Pei-Yuu Yang MD, Fuu-Jen Tsai MD, PhD, Te-Mao Li MD, PhD, Jian-Shiun Chiou MS, Chao-Jung Chen PhD, Ting-Hsu Lin MS, Chiu-Chu Liao MS, Shao-Mei Huang MS, Bo Ban MD, PhD, Wen-Miin Liang PhD, Ying-Ju Lin PhD
Format: Article
Language:English
Published: SAGE Publishing 2019-11-01
Series:Integrative Cancer Therapies
Online Access:https://doi.org/10.1177/1534735419881497
_version_ 1828526001673469952
author Cherry Yin-Yi Chang MD, PhD
Pei-Yuu Yang MD
Fuu-Jen Tsai MD, PhD
Te-Mao Li MD, PhD
Jian-Shiun Chiou MS
Chao-Jung Chen PhD
Ting-Hsu Lin MS
Chiu-Chu Liao MS
Shao-Mei Huang MS
Bo Ban MD, PhD
Wen-Miin Liang PhD
Ying-Ju Lin PhD
author_facet Cherry Yin-Yi Chang MD, PhD
Pei-Yuu Yang MD
Fuu-Jen Tsai MD, PhD
Te-Mao Li MD, PhD
Jian-Shiun Chiou MS
Chao-Jung Chen PhD
Ting-Hsu Lin MS
Chiu-Chu Liao MS
Shao-Mei Huang MS
Bo Ban MD, PhD
Wen-Miin Liang PhD
Ying-Ju Lin PhD
author_sort Cherry Yin-Yi Chang MD, PhD
collection DOAJ
description Background: Ovarian cancer is the seventh most commonly diagnosed malignancy worldwide and has the highest mortality rate among all gynecological cancers. Chinese herbal medicine (CHM) is widely applied in Taiwan and has been used in integrated therapies to treat patients with cancer. Methods: Patients with ovarian cancer who were registered in the Taiwan Registry for Catastrophic Illness Patients Database between 1997 and 2012 were considered for this study. A 1:1 individual matching by age was implemented. A total of 101 CHM users and 101 non-CHM users were involved. A Cox proportional hazard regression model was applied to evaluate the hazard ratio of overall mortality. The Kaplan-Meier method and log-rank test were used to calculate the cumulative incidence of the overall survival rate. Association rule mining and network analysis were used to analyze CHM prescription patterns. Results: CHM users showed a significantly lower risk of overall mortality than nonusers (hazard ratio = 0.45, 95% confidence interval = 0.23-0.91; P = .0256; multivariate Cox proportional hazard model). The cumulative incidence of the overall survival probability was higher for CHM users than for non-CHM users (log-rank test, P = .0009). Association rule mining and network analysis suggested that the main CHM cluster was associated with the usage of Bu-Zhong-Yi-Qi-Tang, Chuan-Xiong, and Xi-Xin, followed by the use of Bai-Shao, Da-Huang, and Di-Huang. Conclusions: CHM, as an adjunctive therapy, may reduce the overall mortality in patients with ovarian cancer. A list of herbal medicines that could potentially be used in future studies and clinical trials has also been provided.
first_indexed 2024-12-11T21:15:34Z
format Article
id doaj.art-7cf23443587349d182026fed077558c6
institution Directory Open Access Journal
issn 1534-7354
1552-695X
language English
last_indexed 2024-12-11T21:15:34Z
publishDate 2019-11-01
publisher SAGE Publishing
record_format Article
series Integrative Cancer Therapies
spelling doaj.art-7cf23443587349d182026fed077558c62022-12-22T00:50:35ZengSAGE PublishingIntegrative Cancer Therapies1534-73541552-695X2019-11-011810.1177/1534735419881497Integrated Chinese Herbal Medicine Therapy Improves the Survival of Patients With Ovarian CancerCherry Yin-Yi Chang MD, PhD0Pei-Yuu Yang MD1Fuu-Jen Tsai MD, PhD2Te-Mao Li MD, PhD3Jian-Shiun Chiou MS4Chao-Jung Chen PhD5Ting-Hsu Lin MS6Chiu-Chu Liao MS7Shao-Mei Huang MS8Bo Ban MD, PhD9Wen-Miin Liang PhD10Ying-Ju Lin PhD11China Medical University Hospital, TaichungTaipei Medical University Hospital, TaipeiAsia University, TaichungChina Medical University, TaichungChina Medical University, TaichungChina Medical University, TaichungChina Medical University Hospital, TaichungChina Medical University Hospital, TaichungChina Medical University Hospital, TaichungChinese Research Center for Behavior Medicine in Growth and Development, Jining, Shandong, ChinaChina Medical University, TaichungChina Medical University, TaichungBackground: Ovarian cancer is the seventh most commonly diagnosed malignancy worldwide and has the highest mortality rate among all gynecological cancers. Chinese herbal medicine (CHM) is widely applied in Taiwan and has been used in integrated therapies to treat patients with cancer. Methods: Patients with ovarian cancer who were registered in the Taiwan Registry for Catastrophic Illness Patients Database between 1997 and 2012 were considered for this study. A 1:1 individual matching by age was implemented. A total of 101 CHM users and 101 non-CHM users were involved. A Cox proportional hazard regression model was applied to evaluate the hazard ratio of overall mortality. The Kaplan-Meier method and log-rank test were used to calculate the cumulative incidence of the overall survival rate. Association rule mining and network analysis were used to analyze CHM prescription patterns. Results: CHM users showed a significantly lower risk of overall mortality than nonusers (hazard ratio = 0.45, 95% confidence interval = 0.23-0.91; P = .0256; multivariate Cox proportional hazard model). The cumulative incidence of the overall survival probability was higher for CHM users than for non-CHM users (log-rank test, P = .0009). Association rule mining and network analysis suggested that the main CHM cluster was associated with the usage of Bu-Zhong-Yi-Qi-Tang, Chuan-Xiong, and Xi-Xin, followed by the use of Bai-Shao, Da-Huang, and Di-Huang. Conclusions: CHM, as an adjunctive therapy, may reduce the overall mortality in patients with ovarian cancer. A list of herbal medicines that could potentially be used in future studies and clinical trials has also been provided.https://doi.org/10.1177/1534735419881497
spellingShingle Cherry Yin-Yi Chang MD, PhD
Pei-Yuu Yang MD
Fuu-Jen Tsai MD, PhD
Te-Mao Li MD, PhD
Jian-Shiun Chiou MS
Chao-Jung Chen PhD
Ting-Hsu Lin MS
Chiu-Chu Liao MS
Shao-Mei Huang MS
Bo Ban MD, PhD
Wen-Miin Liang PhD
Ying-Ju Lin PhD
Integrated Chinese Herbal Medicine Therapy Improves the Survival of Patients With Ovarian Cancer
Integrative Cancer Therapies
title Integrated Chinese Herbal Medicine Therapy Improves the Survival of Patients With Ovarian Cancer
title_full Integrated Chinese Herbal Medicine Therapy Improves the Survival of Patients With Ovarian Cancer
title_fullStr Integrated Chinese Herbal Medicine Therapy Improves the Survival of Patients With Ovarian Cancer
title_full_unstemmed Integrated Chinese Herbal Medicine Therapy Improves the Survival of Patients With Ovarian Cancer
title_short Integrated Chinese Herbal Medicine Therapy Improves the Survival of Patients With Ovarian Cancer
title_sort integrated chinese herbal medicine therapy improves the survival of patients with ovarian cancer
url https://doi.org/10.1177/1534735419881497
work_keys_str_mv AT cherryyinyichangmdphd integratedchineseherbalmedicinetherapyimprovesthesurvivalofpatientswithovariancancer
AT peiyuuyangmd integratedchineseherbalmedicinetherapyimprovesthesurvivalofpatientswithovariancancer
AT fuujentsaimdphd integratedchineseherbalmedicinetherapyimprovesthesurvivalofpatientswithovariancancer
AT temaolimdphd integratedchineseherbalmedicinetherapyimprovesthesurvivalofpatientswithovariancancer
AT jianshiunchioums integratedchineseherbalmedicinetherapyimprovesthesurvivalofpatientswithovariancancer
AT chaojungchenphd integratedchineseherbalmedicinetherapyimprovesthesurvivalofpatientswithovariancancer
AT tinghsulinms integratedchineseherbalmedicinetherapyimprovesthesurvivalofpatientswithovariancancer
AT chiuchuliaoms integratedchineseherbalmedicinetherapyimprovesthesurvivalofpatientswithovariancancer
AT shaomeihuangms integratedchineseherbalmedicinetherapyimprovesthesurvivalofpatientswithovariancancer
AT bobanmdphd integratedchineseherbalmedicinetherapyimprovesthesurvivalofpatientswithovariancancer
AT wenmiinliangphd integratedchineseherbalmedicinetherapyimprovesthesurvivalofpatientswithovariancancer
AT yingjulinphd integratedchineseherbalmedicinetherapyimprovesthesurvivalofpatientswithovariancancer